Cargando…
SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway
Candida albicans is a ubiquitous clinical fungal pathogen. Prolonged use of the first-line antifungal agent fluconazole (FLC) has intensified fungal resistance and limited its effectiveness for the treatment of fungal infections. The combined administration of drugs has been extensively studied and...
Autores principales: | Li, Xiao-Ning, Zhang, Lu-Mei, Wang, Yuan-Yuan, Zhang, Yi, Jin, Ze-Hua, Li, Jun, Wang, Rui-Rui, Xiao, Wei-Lie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596347/ https://www.ncbi.nlm.nih.gov/pubmed/33178156 http://dx.doi.org/10.3389/fmicb.2020.572608 |
Ejemplares similares
-
Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017) -
The Synergism of the Small Molecule ENOblock and Fluconazole Against Fluconazole-Resistant Candida albicans
por: Li, Liping, et al.
Publicado: (2019) -
Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Candida albicans Isolates
por: Xu, Yi, et al.
Publicado: (2017) -
Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans
por: Delarze, Eric, et al.
Publicado: (2020) -
Synergistic Antifungal Effect of Fluconazole Combined with Licofelone against Resistant Candida albicans
por: Liu, Xinning, et al.
Publicado: (2017)